Sanity Group has entered into a strategic transaction agreement to become part of Organigram Global, our longstanding investor.
This transaction brings together two highly complementary businesses: Sanity Group’s Europe-focused platform, brands, and market expertise with Organigram’s scale and strong cultivation and R&D capabilities. Together, we aim to build a stronger platform for international growth in regulated cannabis markets.